APT Medical Inc (688617.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100004C45

Price
258.52 CNY
Market cap
36.59 bn CNY
P/E (2025)
44.42
P/S (2025)
14.16
Dividend yield
0.39 %
Net margin
31.76 %
Return on equity (ROE)
25.82 %
Return on assets (ROA)
22.45 %

APT Medical Inc financials

Fiscal year20242025
Revenue2.07 bn CNY2.58 bn CNY
Gross profit1.49 bn CNY2.58 bn CNY
Operating income753.69 m CNY943.93 m CNY
EBIT748.32 m CNY936.29 m CNY
Net income673.15 m CNY820.64 m CNY
Diluted EPS – continuing operations4.77 CNY5.82 CNY

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About APT Medical Inc

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.

APT Medical Inc stock (688617.SS): P/E, revenue, dividend | finmetric